Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.07.2021 | Case report

Cyclophosphamide/rituximab/prednisolone

Weight gain, mood disturbance followed by lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Higginson J, et al. Tumefactive fibroinflammatory lesion of the maxilla: Successful resection and microvascular reconstruction after failed medical therapy. Oral and Maxillofacial Surgery 25: 279-288, No. 2, 2021. Available from: URL: http://doi.org/10.1007/s10006-020-00914-y Higginson J, et al. Tumefactive fibroinflammatory lesion of the maxilla: Successful resection and microvascular reconstruction after failed medical therapy. Oral and Maxillofacial Surgery 25: 279-288, No. 2, 2021. Available from: URL: http://​doi.​org/​10.​1007/​s10006-020-00914-y
Metadaten
Titel
Cyclophosphamide/rituximab/prednisolone
Weight gain, mood disturbance followed by lack of efficacy: case report
Publikationsdatum
01.07.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-99059-6

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Selinexor

Case report

BCG-vaccine

Case report

Palbociclib